Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in Endocrinology Jg. 14
Hauptverfasser: Sukanya Siriyotha, Thitiya Lukkunaprasit, Teeranan Angkananard, Panu Looareesuwan, Gareth McKay, John Attia, Ammarin Thakkinstian
Format: Journal Article
Sprache:Japanisch
Veröffentlicht: Frontiers Media SA 30.01.2023
Schlagworte:
Adverse effect
antihyperglycemic drugs
Cardiovascular Diseases
Cardiovascular Diseases/epidemiology
cardiovascular events
Continuous Glucose Monitoring
diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2/complications
Dipeptidyl peptidase-4
Dipeptidyl-Peptidase IV Inhibitors
Dipeptidyl-Peptidase IV Inhibitors/therapeutic use
Diseases of the endocrine glands. Clinical endocrinology
dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being
Endocrinology
Endocrinology, Diabetes and Metabolism
FOS: Mathematics
Health Sciences
Humans
Hypoglycemic Agents
Hypoglycemic Agents/therapeutic use
Insulin
Insulin Therapy
Internal medicine
Linagliptin
Management of Diabetes Mellitus and Cardiovascular Risk
Management of Diabetes Mellitus and Hypoglycemia
Mathematics
Medicine
Metformin
Metformin/therapeutic use
Pharmacology
Physical Sciences
RC648-665
Retrospective cohort study
Retrospective Studies
SDG 3 - Good Health and Well-being
second-line
Statistical Methods in Clinical Trials and Drug Development
Statistics and Probability
Sulfonylurea Compounds
Sulfonylurea Compounds/therapeutic use
Thiazolidinediones
Thiazolidinediones/therapeutic use
Treatment Outcome
Type 2 diabetes
Type 2 Diabetes Mellitus
Type 2/complications
ISSN:1664-2392
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
ISSN:1664-2392
DOI:10.60692/9pz6w-h1v77